NR4A1 and breast cancer: The spinal marrow PDFF, BMD values at the femoral neck, total hip, and lumbar spine from the hormone-receptor-positive early breast cancer patients receiving AI treatment and healthy controls at baseline condition and at 6 and 12 months are shown in Figure 3.